Updated on 11 August 2026
Seeking an eligible European consortium for a healthcare AI challenge and evaluation workstream
Internal Medicine Specialist | Clinical AI Safety and Evaluation Researcher at Göktuğ Özkan — Independent Clinical-AI Research
Istanbul, Türkiye
About
Target topic
HORIZON-CL4-2027-04-DIGITAL-EMERGING-04 — Apply AI: Challenge-Driven AI Innovation Booster in Apply AI prioritised sectors
Proposed cooperation
The target topic calls for a challenge-driven project in one strategic sector, with healthcare guaranteed portfolio coverage if a proposal passes all thresholds. It requires a multi-stage competition, user-industry core partners, SME participation, measurable KPIs, benchmarking, and a solid evaluation methodology.
SAFE-CLINAI is proposed as the clinical challenge-design and evaluation layer for such a consortium. It would support:
• synthetic, traceable clinical challenge cases and controlled adversarial variants;
• clinician-authored evaluation criteria and blinded review workflows;
• metrics for clinical correctness, harmful omission, unsupported confidence, evidence traceability, robustness, and workflow usefulness;
• repeatable regression testing across challenge stages;
• transparent scoring, adjudication, and evaluation governance;
• translation of evaluation findings into actionable feedback for participating AI teams.
What I bring
I am an Internal Medicine Specialist and clinical-AI safety researcher working in an individual capacity. TurKMedBench provides a research seed for the proposed method: a historical hematology study used 24 synthetic cases across five models, producing 120 responses for structured failure analysis. It is not a clinically validated product, and the multi-specialty expansion remains controlled work in progress.
I can contribute to clinical use-case definition, challenge specifications, synthetic case design, safety and uncertainty criteria, evidence-traceability scoring, clinician-review workflows, and evaluation governance.
Partners sought
• An eligible European coordinator with Horizon Europe RIA and FSTP experience
• Healthcare user-industry organisations able to act as core partners and support future uptake
• AI SMEs, model developers, data/platform providers, and challenge infrastructure teams
• Hospitals, universities, and clinical research organisations from eligible countries
• Experts in ethics, regulatory strategy, data governance, exploitation, communication, and impact
Collaboration and eligibility note
The concept is at consortium-building stage; no institutional or partner commitment is implied. The current topic text does not list Türkiye among eligible beneficiary countries. Any role for me or a Türkiye-based organisation must therefore be structured and confirmed as legally compliant under the final topic conditions and applicable employment rules before commitment.
Contact
Göktuğ Özkan, MD
Internal Medicine Specialist | Clinical AI Safety and Evaluation Researcher
Stage
- Early
Topic
- AI-GenAI /Data/Robotics
Type
- Partner seeks Consortium
Similar opportunities
Project cooperation
Kazuhiro Matsuda
CEO & Founder at M Bio Technology Inc.
TOKYO, Japan
Project cooperation
Energy and data-centre evidence workflows: partner seeking R&D consortium
- Early
- Sustainability
- Energy Efficiency
- AI-GenAI /Data/Robotics
- Partner seeks Consortium
Corey Foggo
Co-Founder at Mycelium
Lilydale, Australia
Project cooperation
Horizon Europe Partners — Human–AI Collaboration, Workforce Training & Knowledge Transfer
Maziar Firoozmand
Co-Founder & CMO at Odise Studio (Artbees)
Istanbul, Türkiye